Mahoney Robert Patrick 4
4 · Comera Life Sciences Holdings, Inc. · Filed Sep 28, 2023
Insider Transaction Report
Form 4
Mahoney Robert Patrick
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Purchase)
2023-09-27+300,000→ 300,000 totalExercise: $0.38Exp: 2033-09-27→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the stock option vest on September 27, 2024, with the remaining shares vesting on a monthly basis on the 27th day of each month thereafter, in each case, subject to continuous service to the issuer, such that the option shall be fully vested on September 27, 2027.